Dr Ophira Ginsburg
Dr. Ginsburg is a medical oncologist and global women’s health researcher with nearly 20 years of experience in global cancer prevention and control. In 2022 she joined the U.S. National Cancer Institute, as a Senior Scientific Officer and Senior Advisor for Clinical Research at the Center for Global Health. Formerly based at the University of Toronto, Canada, she was a Medical Officer at the World Health Organization (WHO) Headquarters in Geneva, Switzerland (2015-2016) and has served as an ad hoc consultant to several UN agencies. From 2017-2021 she was the Director of the High-Risk Cancer Genetics Program at the Perlmutter Cancer Center, an NCI Designated Comprehensive Cancer Center, and an Associate Professor in the Departments of Population Health and Medicine at NYU Grossman School of Medicine. In 2021 Dr. Ginsburg was appointed as a Senior Visiting Scientist at the International Agency for Research on Cancer (IARC), the WHO’s specialized cancer agency. Her research is focused on improving equitable access to breast and cervical cancer prevention and control. She has authored >100 publications including commentaries in The Lancet, The Lancet Oncology, Journal of Clinical Oncology, Nature Cancer, and Nature Reviews Clinical Oncology. She currently co-chairs The Lancet Commission on Women and Cancer.